Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
JEG-3 |
Human placenta choriocarcinoma cell line | ATCC HTB-36 | Human | respiratory system | cell line | adherent | plasmid | DOTAP | publication | K. D. S. A. Wansa et al., J. Mol. Endocrinol., Jun 2005; 34: 835 - 848 | Link | ||
JEG-3 |
Human placenta choriocarcinoma cell line | ATCC HTB-36 | Human | respiratory system | cell line | adherent | plasmid | Metafectene | publication | T. Allen et al., Diabetes, Sep 2006; 55: 2523 - 2533 | Link | ||
JEG-3 |
Human placenta choriocarcinoma cell line | ATCC HTB-36 | Human | respiratory system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | M.-J. Stahnke et al., Cellular Signalling, 2014, 26 :1792-1799doi.org/10.1016/j.cellsig.2014.04.006 | ||
JEG-3 |
Human placenta choriocarcinoma cell line | ATCC HTB-36 | Human | respiratory system | cell line | adherent | plasmid | Metafectene | publication | K. D. S. A. Wansa et al., J. Mol. Endocrinol., Jun 2005; 34: 835 - 848 | Link | ||
JEG-3 |
Human placenta choriocarcinoma cell line | ATCC HTB-36 | Human | respiratory system | cell line | adherent | plasmid | DOTAP | publication | T. Allen et al., Diabetes, Sep 2006; 55: 2523 - 2533 | Link | ||
JEG-3 |
Human placenta choriocarcinoma cell line | ATCC HTB-36 | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | J. E. D. Escobar, Universität Hamburg | Link | ||
LLC1 |
Lewis Lung carcinoma cell line (Mouse) | Mouse | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | H.F. Alkan et al., bioRxiv preprint, 2020, doi.org/10.1101/2020.05.28.114629 | Link | |||
MLEC32 |
Mink epithelial lung cells | Mink | respiratory system | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | plasmid | Metafectene | publication | S. W. Lee et al., EMBO J., Nov 2012; 31: 4441 - 4452 | Link | ||
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. .I Koukourakis et al., Laboratory Investigation, 2017, 97: 1321-1331, doi:10.1038/labinvest.2017.79 | ||
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | plasmid | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | ||
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-C. Chiang, University of Sussex | Link | |
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | |
MRC5VA |
Human SV40-transformed lung fibroblast cell line | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Abramowicz et al., Hum. Mol. Genet., Dec 2016, DOI: 10.1093/hmg/ddw364 | |||
MRC5VA |
Human SV40-transformed lung fibroblast cell line | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Abramowicz ez al., HMG Advance Access, 2016 | |||
MSTO-211H |
Human lung biphasic mesothelioma cell line | ATCC CRL-2081 | Human | respiratory system | cell line | adherent | plasmid | Metafectene | publication | S. Abe et al., J. Immunol., Jun 2013; 190: 6239 - 6249 | Link | ||
Mv1Lu |
Mink lung epithelial cell line | ATCC CCL-64 | Mink | respiratory system | cell line | adherent | plasmid | K2 Transfection System | publication | M. Ilgu et al., Methods, 2016, 98: 26-33, doi.org/10.1016/j.ymeth.2015.12.009 | |||
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | plasmid | Metafectene | publication | U. K. Mukhopadhyay et al., Cytokine, 2016; 82: 70-79; doi.org/10.1016/j.cyto.2016.01.013 | |||
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. Lo et al., Oncogene, 2015, 34:1688-1697; doi:10.1038/onc.2014.103 | ||
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | D. Lo et al., Oncogene, 2015, 34:1688-1697; doi:10.1038/onc.2014.103 | ||
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M.-J. Kim et al., Cancer Letters, 2013, 339: 15–24, doi.org/10.1016/j.canlet.2013.07.027 | Link | |
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. V. Karagounis et al., British Journal of Cancer, 2016, 115: 312-321; doi: 10.1038/bjc.2016.202 | Link | |
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | W. Huang, PhD Thesis, 2014, Indiana University | Link | |
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | plasmid | Metafectene | publication | J. H. Park et al., Nature Communications, 2016, 7:12513; DOI: 10.1038/ncomms12513 | Link | ||
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | D. Lo et al., Oncogene, 2015, 34:1688-1697; doi:10.1038/onc.2014.103 |